Jack Reed sold SPDR S&P Biotech ETF (XBI)
Jack Reed (D-RI), a U.S. Senator, has disclosed 4 trades in SPDR S&P Biotech ETF (XBI) since 2014, 3 purchases and 1 sale, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Jack Reed sold $1,001 - $15,000 of SPDR S&P Biotech ETF (XBI) on March 9, 2018. Since that trade, XBI is up +54.89% against the S&P 500 up +197.20%, an outperformance of -142.31%.
Across these filings, Jack Reed has been a net buyer of XBI (a buy-to-sell ratio of 3.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Jack Reed's XBI trades vs the price
XBI is up +54.89% since Jack Reed sold on March 9, 2018, versus +197.20% for the S&P 500.
Performance since this trade
All Jack Reed XBI trades
Jack Reed & XBI trading FAQ
Is it legal for Jack Reed to trade SPDR S&P Biotech ETF (XBI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including SPDR S&P Biotech ETF (XBI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Jack Reed sell XBI?
Jack Reed disclosed a sale of $1,001 - $15,000 of SPDR S&P Biotech ETF (XBI) on March 9, 2018, according to public STOCK Act filings.
How has XBI performed since Jack Reed's trade?
Since Jack Reed sold XBI on March 9, 2018, the stock is up +54.89%, versus +197.20% for the S&P 500 over the same period, an outperformance of -142.31%.
How many times has Jack Reed traded XBI?
Jack Reed has disclosed 4 XBI trades since 2014 (3 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional XBI trades?
Quantellect tracks every disclosed congressional trade in SPDR S&P Biotech ETF (XBI) on the SPDR S&P Biotech ETF congressional trading page, which aggregates filings across all members of Congress.
Jack Reed's XBI tradesAll congressional filings for SPDR S&P Biotech ETFJack Reed's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.